Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

Analysts said the move comes amid rising trade tensions with the U.S. and as Illumina faces stiff competition in China’s ...

The U.S. tariffs on China include a broad 10% levy on imported goods. China’s response was more targeted, with 15% tariffs on ...

Illumina and Regeneron are taking stakes in ... of Health’s All of Us million-person program and other massive DNA sequencing projects. The companies—supported by more than a dozen major ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with ...

On the biopharma side of things, Nvidia is teaming up with DNA sequencing powerhouse Illumina. Illumina will ... organization focusing on biology and machine learning, to develop AI tools to ...

Meanwhile, it doesn't seem coincidental that Illumina, which is the most significant genetic sequencing business in the world, has a large Chinese rival in biotech BGI Genomics. Ever feel like you ...

ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, is delighted ...

Over the last six months, ANGLE has overcome technical issues to successfully use Illumina assays ... Parsortix-based CTC analysis for DNA dual analysis NGS sequencing, enabling analysis of ...

Angle plc, a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) solutions for use in research, drug development and clinical oncology, has announced new, successful ...